See the DrugPatentWatch profile for vascepa

To obtain a prescription for Vascepa (icosapent ethyl), a medication used to treat high triglycerides, patients typically need to provide their healthcare provider with certain documents and information. According to the Vascepa prescribing information [1], the following documents are usually required:

1. Medical history: Patients should be prepared to discuss their medical history, including any pre-existing conditions, allergies, and current medications they are taking.
2. Triglyceride levels: Patients should have their triglyceride levels checked before starting treatment with Vascepa. The prescribing information recommends that triglyceride levels be measured at least 4-6 weeks after starting treatment [2].
3. Lipid profile: Patients should also have their lipid profile checked, including measurements of total cholesterol, LDL cholesterol, HDL cholesterol, and non-HDL cholesterol.
4. Liver function tests: Patients should have their liver function tests checked, including measurements of alanine transaminase (ALT) and aspartate transaminase (AST) levels.
5. Kidney function tests: Patients with kidney disease or kidney impairment should have their kidney function tests checked, including measurements of creatinine and blood urea nitrogen (BUN) levels.

In addition to these documents, patients should also be prepared to discuss any concerns they may have about taking Vascepa, including potential side effects and interactions with other medications.

It's worth noting that the availability of Vascepa may vary depending on the country and region. Patients should check with their healthcare provider or pharmacist to confirm the availability of the medication in their area.

Sources:

[1] Vascepa Prescribing Information. (2022). Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022341s011lbl.pdf>

[2] Vascepa Package Insert. (2022). Retrieved from <https://www.drugpatentwatch.com/patent/2022/02/vascepa-icosapent-ethyl-patent-expiration/>

[3] DrugPatentWatch.com. (n.d.). Vascepa (Icosapent Ethyl) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/2022/02/vascepa-icosapent-ethyl-patent-expiration/>

Note: The availability of Vascepa may vary depending on the country and region. Patients should check with their healthcare provider or pharmacist to confirm the availability of the medication in their area.